Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters










Publication year range
1.
Appl Radiat Isot ; 209: 111326, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38701595

ABSTRACT

Thorium-227 was separated from its progeny and standardized for activity by the triple-to-double coincidence ratio (TDCR) method of liquid scintillation counting. Confirmatory liquid scintillation-based measurements were made using efficiency tracing with 3H and live-timed anticoincidence counting (LTAC). The separation time and the efficiency of the separation were confirmed by gamma-ray spectrometry. Calibrations for reentrant pressurized ionization chambers, including commercial radionuclide calibrators, and a well-type NaI(Tl) detector are discussed.

2.
Appl Radiat Isot ; 203: 111108, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38000166

ABSTRACT

Gadolinium-153 was standardized for activity by live-timed anticoincidence counting and an ampoule was submitted to the international reference system (SIR). Absolute emission intensities for the main γ rays were determined with calibrated high-purity germanium (HPGe) and lithium-drifted silicon (Si(Li)) detectors. A revised decay scheme is indicated, with no probability of direct electron capture to the 153Eu ground state. Triple-to-double coincidence ratio (TDCR) efficiency curves indicate that the revised decay scheme is consistent with experiment. Half-life measurements agree with a previous NIST determination and show no sensitivity to chemical environment.

3.
Appl Radiat Isot ; 190: 110473, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36201936

ABSTRACT

An activity standard for 212Pb in equilibrium with its progeny was realized, based on triple-to-double coincidence ratio (TDCR) liquid scintillation (LS) counting. A Monte Carlo-based approach to estimating uncertainties due to nuclear decay data (branching ratios, beta endpoint energies, γ-ray energies, and conversion coefficients for 212Pb and 208Tl) led to combined standard uncertainties ≤ 0.20 %. Confirmatory primary measurements were made by LS efficiency tracing with tritium and 4παß(LS)-γ(NaI(Tl)) anticoincidence counting. The standard is discussed in relation to current approaches to 212Pb activity calibration. In particular, potential biases encountered when using inappropriate radionuclide calibrator settings are discussed.


Subject(s)
Lead , Scintillation Counting , Scintillation Counting/methods , Radioisotopes , Tritium/analysis , Reference Standards
4.
Appl Radiat Isot ; 170: 109572, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33461017

ABSTRACT

The national metrology institutes for the United Kingdom (UK) and the United States of America (USA) have compared activity standards for 224Ra, an α-particle emitter of interest as the basis for therapeutic radiopharmaceuticals. Solutions of 224RaCl2 were assayed by absolute methods, including digital coincidence counting and triple-to-double coincidence ratio liquid scintillation counting. Ionization chamber and high-purity germanium (HPGe) γ-ray spectrometry calibrations were compared; further, a solution was shipped between laboratories for a direct comparison by HPGe spectrometry. New determinations of the absolute emission intensity for the 241 keV γ ray (Iγ = 4.011(16) per 100 disintegrations of 224Ra) and of the 224Ra half-life (T1/2 = 3.6313(14) d) are presented and discussed in the context of previous measurements and evaluations.

5.
Appl Radiat Isot ; 164: 109265, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32763787

ABSTRACT

A suspension of 224Ra adsorbed onto CaCO3 microparticles shows promise for α-therapy of intracavitary micro-metastatic diseases. To facilitate accurate activity administrations, geometry-specific calibration factors for commercially available reentrant ionization chambers (ICs) have been developed for 224RaCl2 solutions and 224Ra adsorbed onto CaCO3 microparticles in suspension in ampoules, vials, and syringes. Ampoules and vials give IC responses consistent with each other to <1%. Microparticles attenuation leads to a ≈1% to ≈2.5% reduction in response in the geometries studied.

6.
Appl Radiat Isot ; 155: 108933, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31654881

ABSTRACT

A standard for activity of 224Ra in secular equilibrium with its progeny has been developed, based on triple-to-double coincidence ratio (TDCR) liquid scintillation (LS) counting. The standard was confirmed by efficiency tracing and 4παß(LS)-γ(NaI(Tl)) anticoincidence counting, as well as by 4πγ ionization chamber and NaI(Tl) measurements. Secondary standard ionization chambers were calibrated with an expanded uncertainty of 0.62% (k = 2). Calibration settings were also determined for a 5 mL flame-sealed ampoule on several commercial reentrant ionization chambers (dose calibrators).

7.
Nucl Med Commun ; 39(6): 500-504, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29596133

ABSTRACT

BACKGROUND: Most clinical measurements of radioactivity, whether for therapeutic or imaging nuclides, rely on commercial re-entrant ionization chambers ('dose calibrators'). The National Institute of Standards and Technology (NIST) maintains a battery of representative calibrators and works to link calibration settings ('dial settings') to primary radioactivity standards. Here, we provide a summary of NIST-determined dial settings for 22 radionuclides. METHODS: We collected previously published dial settings and determined some new ones using either the calibration curve method or the dialing-in approach. RESULTS: The dial settings with their uncertainties are collected in a comprehensive table. CONCLUSION: In general, current manufacturer-provided calibration settings give activities that agree with National Institute of Standards and Technology standards to within a few percent.


Subject(s)
Nuclear Medicine/methods , Radiation Dosage , Radioisotopes , Calibration
8.
Article in English | MEDLINE | ID: mdl-30996507

ABSTRACT

A new nuclear forensic reference material has been characterized as a standard for radiochronometric determination of the model purification date for 137Cs sources. The purification date of a radioactive source is a potentially diagnostic nuclear forensic signature for determining the provenance of a radioactive material. Reference values have been measured for the attributes needed to use the 137Cs/137Ba chronometer: the molality (reported here as nmol g-1) of 137Cs and of the radiogenic portion of 137Ba in the material (hereafter referred to as 137Ba*). All measurement results were decay-corrected to represent the composition of the material on the reference date of July 7, 2011. The molality of 137Cs is (0.7915 ± 0.0073) nmol g-1; this value was calculated from the massic activity of 137Cs, (348.4 ± 3.0) kBq g-1, as measured in the NIST 4π-γ secondary standard ionization chamber (previously calibrated by 4π-(e+x)-γ-coincidence efficiency extrapolation counting) and the evaluated half-life of 137Cs, (30.05 ± 0.08) years. The molality of 137Ba*, (1.546 ± 0.024) nmol g-1, was measured by isotope dilution mass spectrometry using the measured relative proportion of 138Ba in the material to apply a correction for the 137Ba contribution from natural Ba. A model age of (47.04 ± 0.56) years, corresponding to a model purification date of June 22, 1964 with an expanded uncertainty of 200 days is calculated from the reference material values. This age is consistent with the date engraved on the capsule that contained the 137Cs starting material and with a prior independent determination of the model purification date. A full discussion of the uncertainties of the reference material values is included.

9.
Appl Radiat Isot ; 134: 416-420, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29100721

ABSTRACT

In nuclear medicine, 68Ge is used to generate 68Ga for imaging by positron emission tomography (PET) and sealed sources containing 68Ge/68Ga in equilibrium have been adopted as long-lived calibration surrogates for the more common PET nuclide, 18F. We prepared several 68Ge sources for measurement on a NaI(Tl) well counter and a pressurized ionization chamber, following their decay for 110 weeks (≈ 2.8 half-lives). We determined values for the 68Ge half-life of T1/2 = 271.14(15) d and T1/2 = 271.07(12) d from the NaI(Tl) well counter and ionization chamber measurements, respectively. These are in accord with the current Decay Data Evaluation Project (DDEP) recommended value of T1/2 = 270.95(26) d and we discuss the expected impact of our measurements on this value.

10.
Appl Radiat Isot ; 109: 402-404, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26717794

ABSTRACT

Source self-attenuation for solutions of (57)Co of varying density and carrier concentration was measured in nine re-entrant ionization chambers maintained at NIST. The magnitude of the attenuation must be investigated to determine whether a correction is necessary in the determination of the activity of a source that differs in composition from the source used to calibrate the ionization chamber. At our institute, corrections are currently made in the measurement of (144)Ce, (109)Cd, (67)Ga, (195)Au, (166)Ho, (177)Lu, and (153)Sm. This work presents the methods used as recently applied to (57)Co. A range of corrections up to 1% were calculated for dilute to concentrated HCl at routinely used carrier concentrations.

11.
J Nucl Med ; 56(9): 1453-7, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26182967

ABSTRACT

UNLABELLED: As a result of a recent change in the National Institute of Standards and Technology (NIST) activity standard for (18)F, we have determined new relative response ratios for a (68)Ge solid epoxy mock syringe source used in activity calibrators as a long-lived substitute for (18)F. New standardized solutions of each radionuclide were used to determine the response ratios while maintaining traceability to national standards. This work updates our previously published data from 2010. METHODS: Following our previously published methodology, solution-filled mock syringe sources, identical in geometry to the solid (68)Ge epoxy calibration source currently on the market, were prepared using NIST-calibrated solutions of (68)GeCl4 and (18)F-FDG and directly compared in several models of activity calibrators to determine empirically the relative response ratios for these 2 radionuclides. RESULTS: The new relative response ratios measured in this study reflect the change in (18)F activity measurements that arise from the recent -4% change in the NIST activity standard. The results allow the (68)Ge activity of the mock syringe source to be expressed in terms of equivalent (18)F activity, with a relative combined standard uncertainty of about 0.8% for the activity calibrators used in this study. CONCLUSION: This work revises our previously derived relative response ratios for (18)F and (68)Ge by -3.7%, allowing users of the commercial mock syringe surrogate source to calibrate their activity calibrators in a way that is consistent with the recent change in the NIST (18)F standard.


Subject(s)
Fluorine Radioisotopes/analysis , Fluorine Radioisotopes/standards , Germanium/analysis , Germanium/standards , Guidelines as Topic , Radiometry/standards , Materials Testing/standards , Nuclear Medicine/standards , Radiation Dosage , Radiopharmaceuticals/analysis , Radiopharmaceuticals/standards , Reproducibility of Results , Sensitivity and Specificity , Syringes , United States
12.
Appl Radiat Isot ; 101: 10-14, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25813001

ABSTRACT

Dose calibrator dial settings reported by NIST in 2010 (ARI, v. 68, p. 1367) are now known to give erroneously low (by 10%) activity readings. The original determinations were based on a chain of calibrations; a broken link in this chain was recently discovered. New calibration factors (i.e., dial settings), directly linked to updated NIST primary standards, are reported here. In addition, the raw data used to derive the factors reported in 2010 are revisited. The validity of the reevaluation is established via comparison with the new experiments and revised calibration factors for numerous clinical geometries are reported. The main conclusions of the 2010 report regarding geometry effects remain valid.

13.
Appl Radiat Isot ; 90: 79-83, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24705009

ABSTRACT

Calibration factors for commercial ionization chambers (i.e. dose calibrators) were determined for a solution of (123)I; the activity was based on the 1976 NBS standard. A link between the NIST standard and the International Reference System (SIR) was established. The two major U.S. dose calibrator manufacturers recommend oppositely biased calibration factors, giving a spread of 11.3% in measured activities. With modern quantitative imaging techniques capable of ≤10% accuracy, this bias for a SPECT nuclide is highly significant.

14.
J Res Natl Inst Stand Technol ; 119: 371-96, 2014.
Article in English | MEDLINE | ID: mdl-26601035

ABSTRACT

The new NIST activity standardization for (18)F, described in 2014 in Applied Radiation and Isotopes (v. 85, p. 77), differs from results obtained between 1998 and 2008 by 4 %. The new results are considered to be very reliable; they are based on a battery of robust primary measurement techniques and bring the NIST standard into accord with other national metrology institutes. This paper reviews all ten (18)F activity standardizations performed at NIST from 1982 to 2013, with a focus on experimental variables that might account for discrepancies. We have identified many possible sources of measurement bias and eliminated most of them, but we have not adequately accounted for the 1998-2008 results.

15.
Appl Radiat Isot ; 70(9): 2227-31, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22578995

ABSTRACT

The National Institute of Standards and Technology (NIST) maintains a program for the establishment and dissemination of activity measurement standards in nuclear medicine. These standards are disseminated through Standard Reference Materials (SRMs), Calibration Services, radionuclide calibrator settings, and the NIST Radioactivity Measurement Assurance Program (NRMAP, formerly the NEI/NIST MAP). The MAP for the radiopharmaceutical industry is described here. Consolidated results show that, for over 3600 comparisons, 96% of the participants' results differed from that of NIST by less than 10%, with 98% being less than 20%. Individual radionuclide results are presented from 214 to 439 comparisons, per radionuclide, for (67)Ga, (90)Y, (99m)Tc, (99)Mo, (111)In, (125)I, (131)I, and (201)Tl. The percentage of participants results within 10% of NIST ranges from 88% to 98%.


Subject(s)
Drug Industry/standards , Government Programs , Quality Assurance, Health Care/standards , Radiometry/standards , Radiopharmaceuticals/analysis , Radiopharmaceuticals/standards , Radiation Dosage , Reference Standards , Reference Values , United States
16.
Appl Radiat Isot ; 70(9): 2170-5, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22436452

ABSTRACT

In the triple-to-double coincidence ratio (TDCR) method of liquid scintillation counting, unaccounted or improperly accounted impurities can result in lower-than-expected or higher-than-expected recovered activities, depending on the counting efficiency of the nuclide of interest, the counting efficiency of the radionuclidic impurity, and the amount of impurity present. We describe these general dependences using a simple model. The trends predicted by the model are tested experimentally using a series of mixed (241)Am/(3)H and (63)Ni/(3)H sources. An "impurity surface" is derived to facilitate an intuitive grasp of impurity phenomena in TDCR.


Subject(s)
Artifacts , Complex Mixtures/analysis , Models, Chemical , Radioisotopes/analysis , Scintillation Counting/methods , Computer Simulation , Radiation Dosage
17.
J Nucl Med ; 51(3): 448-53, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20197450

ABSTRACT

UNLABELLED: We have developed a methodology for calibrating (68)Ge radioactivity content in a commercially available calibration source for activity calibrators in a way that is traceable to the national standard. Additionally, the source was cross-calibrated for equivalent (18)F content by direct comparison with the national standard for (18)F in the same geometry. METHODS: Sources containing standardized (68)GeCl(4) or (18)F-FDG solutions were prepared at the National Institute of Standards and Technology (NIST) with mock syringe blanks used in the construction of a commercially available epoxy-based (68)Ge calibration source. These sources and several NIST-constructed epoxy-based (68)Ge mock syringes were then used as artifact standards to determine calibration factors for NIST-maintained activity calibrators and secondary standard ionization chambers to enable calibration of the actual commercial sources. A direct comparison between the solution-based (68)Ge sources and the (18)F-FDG sources allowed for an empiric determination of the relative response for these radionuclides in several commercial activity calibrators. Potential measurement effects due to differences between the solution composition and the epoxy and theoretic (68)Ge-to-(18)F response ratios were studied by Monte Carlo simulation. RESULTS: The calibration factors developed in this study enabled NIST to calibrate epoxy-based mock syringe sources with a relative combined standard uncertainty of 0.52%. The direct comparisons of the (68)Ge and (18)F standards in the various ionization chambers allowed the activity to be expressed in terms of equivalent (18)F activity with a relative combined standard uncertainty of about 0.9%. CONCLUSION: The ability for NIST to calibrate these epoxy-based mock syringes enabled, for the first time to our knowledge, the direct traceability to the national (68)Ge standard to be established for this type of source. Through a direct comparison with the NIST (18)F standard, the determination of the relative response ratios in activity calibrators enabled the equivalent (18)F activity to be determined in a way that was also traceable to the national (18)F activity standard.


Subject(s)
Calibration/standards , Fluorodeoxyglucose F18 , Germanium , Gallium Radioisotopes , Government Agencies/standards , Radioactivity , Reference Standards , Uncertainty , United States
18.
Appl Radiat Isot ; 68(7-8): 1367-70; discussion 1370, 2010.
Article in English | MEDLINE | ID: mdl-20005730

ABSTRACT

Ra-223 is a bone-seeking alpha emitter currently being evaluated as a radiopharmaceutical. Concurrent with the primary standardization, NIST established that calibration factors currently used for radionuclide calibrators in the clinical setting give readings 5.7-8.7% higher than the NIST calibrated activity. This work describes the determination of calibration factors specific to dose vials and syringes. Using the calibration factors derived with standard ampoules to measure syringe activities can give readings up to 3.6% too high.


Subject(s)
Radon/standards , Bone and Bones/metabolism , Calibration , Radiopharmaceuticals/standards , Reference Standards
19.
Appl Radiat Isot ; 66(2): 252-60, 2008 Feb.
Article in English | MEDLINE | ID: mdl-17933545

ABSTRACT

A blind performance test was conducted to evaluate dose-calibrator measurements at nuclear pharmacies in the United States (US). Two test-sample geometries were chosen to represent those used for measurements of 90Y-ibritumomab tiuxetan (ZEVALIN). The radioactivity concentration of test-samples was verified by the US National Institute of Standards and Technology. Forty-five results were reported by 10 participants. Eighty percent of reported values were within the US Pharmacopoeia content standard (+/-10%) for 90Y-ZEVALIN. All results were within US Nuclear Regulatory Commission conformance limits (+/-20%) for defining therapeutic misadministrations.


Subject(s)
Antibodies, Monoclonal/analysis , Radiopharmaceuticals/analysis , Yttrium Radioisotopes/analysis , Ambulatory Care Facilities/standards , Antibodies, Monoclonal/therapeutic use , Humans , Neoplasms/radiotherapy , Nuclear Medicine/standards , Pharmacies/standards , Pilot Projects , Quality Control , Radioimmunotherapy , Radiometry/methods , Radiometry/standards , Radiopharmaceuticals/standards , Radiopharmaceuticals/therapeutic use , Radiotherapy Dosage , Reference Standards , United States , Yttrium Radioisotopes/standards , Yttrium Radioisotopes/therapeutic use
20.
Appl Radiat Isot ; 64(10-11): 1365-9, 2006.
Article in English | MEDLINE | ID: mdl-16563782

ABSTRACT

A method for assessing the impurity 210At in cyclotron-produced 211At via isotope dilution alpha spectrometry is presented. The activity of 210At is quantified by measuring the activity of daughter nuclide 210Po. Counting sources are prepared by spontaneous deposition of Po on a silver disc. Activity of 210At (at the time of 210Po maximum activity) is found to be 83.5+/-9.0 Bq, corresponding to an atom ratio (210At:211At at the time of distillation) of 0.010+/-0.007% (k=2). The method produces high-quality alpha spectra, with baseline alpha-peak resolution and chemical yields of greater than 85%.


Subject(s)
Alpha Particles , Astatine/analysis , Polonium/analysis , Radioisotope Dilution Technique , Radiometry/methods , Spectrum Analysis/methods , Astatine/chemistry , Astatine/therapeutic use , Drug Evaluation/methods , Polonium/chemistry , Radiation Dosage , Radiopharmaceuticals/analysis , Radiopharmaceuticals/chemical synthesis , Radiopharmaceuticals/therapeutic use , Reproducibility of Results , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...